Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

13 Results

Guidelines and Advice

Optimization of Surgical and Pathological Quality Performance in Radical Surgery for Colon and Rectal Cancer: Margins and Lymph Nodes

Status: In-Review
ID: 17-4
Version: 2

Nov 2016

Guidelines and Advice

Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer

Status: Archived
ID: 17-5

Jul 2016

Guidelines and Advice

Stem Cell Transplantation in the Treatment of Acute Lymphoblastic Leukemia: Recommendations

Status: In-Review
ID: SCT 6

Feb 2016

Guidelines and Advice

Systemic Treatment Computerized Prescriber Order Entry (ST CPOE): Best Practice Guideline for Intravenous and Oral Chemotherapy

Status: Current
ID: GL-C50-26

Feb 2016

Guidelines and Advice

Systemic Treatment of Acute Myeloid Leukemia (AML)

Status: In-Review
ID: 12-9

Jan 2016

Guidelines and Advice

Systemic Therapy in Acute Lymphoblastic Leukemia

Status: Archived
ID: 12-16

Jun 2016

Statistical Reports

Ontario Cancer Statistics 2016

Jun 2016

Cancer facts

Ovarian Cancer Survival Has Increased in Ontario among Most Age Groups

Sep 2016

Cancer facts

Survival Improving for the 4 Most Common Cancers in Ontario

Jun 2016

Cancer facts

Shiftwork, Breast Cancer and Health: Interventions to Reduce the Risks

Apr 2016

Drug

octreotide

Other Name(s): Sandostatin® (multiple brands available) , Sandostatin® LAR™ (Novartis)

Quick Link(s):

Drug Monograph, Patient Info Sheet

Aug 2016

Statistical Reports

Statistiques 2016 sur le cancer en Ontario

Jun 2016

Pages